Literature DB >> 32543628

Customized hydrogel substrates for serum-free expansion of functional hMSCs.

Ngoc Nhi T Le1, Tianran Leona Liu, James Johnston, John D Krutty, Kayla Marie Templeton, Victoria Harms, Andrew Dias, Hau Le, Padma Gopalan, William L Murphy.   

Abstract

We describe a screening approach to identify customized substrates for serum-free human mesenchymal stromal cell (hMSC) culture. In particular, we combine a biomaterials screening approach with design of experiments (DOE) and multivariate analysis (MVA) to understand the effects of substrate stiffness, substrate adhesivity, and media composition on hMSC behavior in vitro. This approach enabled identification of poly(ethylene glycol)-based and integrin binding hydrogel substrate compositions that supported functional hMSC expansion in multiple serum-containing and serum-free media, as well as the expansion of MSCs from multiple, distinct sources. The identified substrates were compatible with standard thaw, seed, and harvest protocols. Finally, we used MVA on the screening data to reveal the importance of serum and substrate stiffness on hMSC expansion, highlighting the need for customized cell culture substrates in optimal hMSC biomanufacturing processes.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32543628      PMCID: PMC7436193          DOI: 10.1039/d0bm00540a

Source DB:  PubMed          Journal:  Biomater Sci        ISSN: 2047-4830            Impact factor:   6.843


  49 in total

1.  Mesenchymal stem cell mechanics from the attached to the suspended state.

Authors:  John M Maloney; Dessy Nikova; Franziska Lautenschläger; Emer Clarke; Robert Langer; Jochen Guck; Krystyn J Van Vliet
Journal:  Biophys J       Date:  2010-10-20       Impact factor: 4.033

2.  Linear viscoelastic behavior of subcutaneous adipose tissue.

Authors:  Marion Geerligs; Gerrit W M Peters; Paul A J Ackermans; Cees W J Oomens; Frank P T Baaijens
Journal:  Biorheology       Date:  2008       Impact factor: 1.875

3.  Correlation between mesh size and equilibrium degree of swelling of polymeric networks.

Authors:  T Canal; N A Peppas
Journal:  J Biomed Mater Res       Date:  1989-10

4.  Endothelial invasive response in a co-culture model with physically-induced osteodifferentiation.

Authors:  Samantha B Traphagen; Igor Titushkin; Shan Sun; Kishore K Wary; Michael Cho
Journal:  J Tissue Eng Regen Med       Date:  2012-06-13       Impact factor: 3.963

5.  Vascular endothelial growth factor principally acts as the main angiogenic factor in the early stage of human osteoblastogenesis.

Authors:  Takayuki Furumatsu; Zheng Nan Shen; Akira Kawai; Keiichiro Nishida; Hironori Manabe; Toshitaka Oohashi; Hajime Inoue; Yoshifumi Ninomiya
Journal:  J Biochem       Date:  2003-05       Impact factor: 3.387

6.  Development and characterization of a clinically compliant xeno-free culture medium in good manufacturing practice for human multipotent mesenchymal stem cells.

Authors:  Lucas G Chase; Sufang Yang; Vladimir Zachar; Zheng Yang; Uma Lakshmipathy; Jolene Bradford; Shayne E Boucher; Mohan C Vemuri
Journal:  Stem Cells Transl Med       Date:  2012-10-10       Impact factor: 6.940

7.  Directing stem cell fate by controlling the affinity and density of ligand-receptor interactions at the biomaterials interface.

Authors:  Kristopher A Kilian; Milan Mrksich
Journal:  Angew Chem Int Ed Engl       Date:  2012-04-13       Impact factor: 15.336

8.  Matrix elasticity in vitro controls muscle stem cell fate in vivo.

Authors:  Matthew Raab; Jae-Won Shin; Dennis E Discher
Journal:  Stem Cell Res Ther       Date:  2010-12-10       Impact factor: 6.832

9.  Ex vivo expansion of human mesenchymal stem cells in defined serum-free media.

Authors:  Sunghoon Jung; Krishna M Panchalingam; Lawrence Rosenberg; Leo A Behie
Journal:  Stem Cells Int       Date:  2012-05-07       Impact factor: 5.443

10.  Controlling osteogenic stem cell differentiation via soft bioinspired hydrogels.

Authors:  Amit K Jha; Wesley M Jackson; Kevin E Healy
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.